Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study

Código QR

Antithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study

Wei Xiang, Jingwei Zhang, Meilin Liu, Fang Liu, Xueru Feng, Yuchuan Wang Department of Geriatrics, Peking University First Hospital, Beijing, People’s Republic of China Objective: Non-valvular atrial fibrillation (NVAF) is one common arrhythmia in the elderly. However, use of antithrombo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xiang W, Zhang JW, Liu ML, Liu F, Feng XR, Wang YC
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Elderly Atrial fibrillation Ischemic stroke Anticoagulation CHA2DS2–VASc score Geriatrics RC952-954.6
Acceso en línea:	https://doaj.org/article/f055d10c9d0f4c188fa29d4af96d3eb5
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Differential Risk of Dementia Between Patients With Atrial Flutter and Atrial Fibrillation: A National Cohort Study
por: Hui-Ting Wang, et al.
Publicado: (2021)

Efficacy of R2CHA2DS2-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation
por: Komsing Methavigul, et al.
Publicado: (2021)

CHA2DS2-VASc score can guide the screening of atrial fibrillation - cross-sectional study in a geriatric ward
por: Wojszel ZB, et al.
Publicado: (2019)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Jia-hui Li, et al.
Publicado: (2021)

Risk evaluation of new-onset atrial fibrillation complicating ST-segment elevation myocardial infarction: a comparison between GRACE and CHA2DS2-VASc scores
por: Luo JC, et al.
Publicado: (2018)

CHADS2 score has a better predictive value than CHA2DS2-VASc score in elderly patients with atrial fibrillation
por: Xing YL, et al.
Publicado: (2016)

A STUDY OF RISK FACTOR PROFILE OF ATRIAL FIBRILLATION APPLYING CHA2DS2-VASC SCORE
por: Ahmed Mustafa, et al.
Publicado: (2021)

Antithrombotic Therapy in Elderly Patients with Atrial Fibrillation: The State of the Problem in the Real Clinical Practice of a Family Medicine Doctor
por: Bazira Kanat кyzy, et al.
Publicado: (2021)

R2(GFR)CHADS2 and R2(GFR)CHA2DS2VASc schemes improved the performance of CHADS2 and CHA2DS2VASc scores in death risk stratification of Chinese older patients with atrial fibrillation
por: Fu S, et al.
Publicado: (2017)

Efectividad y seguridad del tratamiento anticoagulante con acenocumarol en fibrilación auricular no valvular
por: Castro,Constanza, et al.
Publicado: (2017)

Carotid Artery Stenting in Patients with Atrial Fibrillation: Direct Oral Anticoagulants, Brief Double Antiplatelets, and Testing Strategy
por: José E. Cohen, et al.
Publicado: (2021)

Oral anticoagulation to reduce risk of stroke in patients with atrial fibrillation: current and future therapies
por: Amin A
Publicado: (2013)

Metabolomic and Proteomic Analyses of Persistent Valvular Atrial Fibrillation and Non-Valvular Atrial Fibrillation
por: Bo Hu, et al.
Publicado: (2021)

Adoption of the SAMe-TT2R2 score in older patients with atrial fibrillation
por: Stylianos Tzeis, et al.
Publicado: (2021)

Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy – REGATTA)
por: Ekaterina S. Kropacheva, et al.
Publicado: (2021)

Long-term effect of anticoagulation following left atrial appendage occlusion with the LARIAT device in patients with nonvalvular atrial fibrillation: impact on thromboembolism, bleeding and mortality. Real life data
por: Radosław Litwinowicz, et al.
Publicado: (2020)

Prevention of ischemic stroke in atrial fibrillation from the point of view of a neurologist. Standards and real clinical practice
por: Marina Yu. Maksimova, et al.
Publicado: (2021)

Beneficial effects of pre-stroke statins use in cardioembolic stroke patients with atrial fibrillation: a hospital-based retrospective analysis
por: Dariusz Kotlęga, et al.
Publicado: (2019)

Characteristics of warfarin under-prescription in older adults with atrial fibrillation
por: Sana Rashid, et al.
Publicado: (2021)

Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention
por: Marek Koziński, et al.
Publicado: (2020)

The current approach of atrial fibrillation management
por: Anish Amin, et al.
Publicado: (2016)

Combining CHA2DS2-VASc score into RCRI for prediction perioperative cardiovascular outcomes in patients undergoing non-cardiac surgery: a retrospective pilot study
por: Song-Yun Chu, et al.
Publicado: (2021)

Antithrombotic therapy in very elderly patients with atrial fibrillation: Is it enough to assess thromboembolic risk?
por: Yutao Guo, et al.
Publicado: (2010)

Hospitalized frail elderly patients – atrial fibrillation, anticoagulation and 12 months’ outcomes
por: Ekerstad N, et al.
Publicado: (2018)

Características basales, manejo de terapias antitrombóticas y pronóstico de pacientes chilenos con FA no valvular. Lecciones del Registro GARFIELD AF en Chile
por: Corbalán,Ramón, et al.
Publicado: (2017)

Journal of atrial fibrillation

Risk factors of left atrial appendage thrombus in patients with non-valvular atrial fibrillation
por: Liu Yaowu, et al.
Publicado: (2021)

Newly Diagnosed Atrial Fibrillation in Acute Myocardial Infarction
por: Yuki Obayashi, et al.
Publicado: (2021)

ANTICOAGULATION CONTROL AMONG PATIENTS WITH ATRIAL FIBRILLATION
por: Amer Rauf, et al.
Publicado: (2020)

Gender Differences in the Impact of New-Onset Atrial Fibrillation on Long-Term Risk of Ischemic Stroke after Acute Myocardial Infarction
por: Jeong-Eun Yi, et al.
Publicado: (2021)

Patient characteristics, adherence, and costs of oral anticoagulation therapy in non-valvular atrial fibrillation using the Dubai Real-World Claims Database
por: Moutaz El Kadri, et al.
Publicado: (2021)

Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry
por: Sirin Apiyasawat, et al.
Publicado: (2021)

Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry
por: Krittayaphong R, et al.
Publicado: (2021)

Temporal Trends of Antithrombotic Therapy in Patients With Acute Myocardial Infarction and Atrial Fibrillation: Insight From the KAMIR-NIH Registry
por: Oh-Hyun Lee, et al.
Publicado: (2021)

Periprocedural and Short‐Term Outcomes of Percutaneous Left Atrial Appendage Closure According to Type of Atrial Fibrillation
por: Toshiaki Isogai, et al.
Publicado: (2021)

Racial and Urban-Rural Difference in the Frequency of Ischemic Stroke as Initial Manifestation of Atrial Fibrillation
por: Jingchuan Guo, et al.
Publicado: (2021)

Antithrombotic therapy and its impact on prognosis in patients with atrial fibrillation and myocardial infarction. Long-term observation results
por: Mariia V. Soloveva, et al.
Publicado: (2021)

Avances en la prevención de eventos tromboembólicos en pacientes con fibrilación auricular
por: Montagna M,Rodrigo, et al.
Publicado: (2007)

Antithrombotic therapy in patients with atrial fibrillation and coronary artery disease
por: Abdelmoniem Moustafa, et al.
Publicado: (2019)

Causal effects of atrial fibrillation on brain white and gray matter volume: a Mendelian randomization study
por: Sehoon Park, et al.
Publicado: (2021)